Member? Please login
Written by BCCJ
September 3, 2018
The BCCJ is Delighted to welcome Abcam on becoming a Corporate Member!
As an innovator in reagents and tools, Abcam’s purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, Abcam offers highly validated biological binders and assays to address important targets in critical biological pathways.
Already a pioneer in data sharing and ecommerce in the life sciences, Abcam’s ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world’s 750,000 life science researchers use Abcam’s affinity binders, reagents, biomarkers, and assays, and the company’s products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.
By actively listening to and collaborating with researchers, Abcam continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.
Abcam opened a Japan office in 2006 and has over 30 employees responsible for sales and marketing, distribution and operations (customer service, scientific support and logistics) to the Japanese market. Abcam’s revenue in Japan in FY2017 was ￡17.3m representing approx. 7% of global sales.
Abcam has twelve locations located in the world’s leading life science research hubs, enabling local services and multi-language support. Founded in 1998 and headquartered in Cambridge, UK, the company sells to more than 100 countries. Abcam was admitted to AIM in 2005 (AIM: ABC).
For more information, please visit Abcam’s customer-facing website www.abcam.co.jp or investor relations site www.abcamplc.com. Alternatively, please contact Abcam KK General Manager Nick Lines ([email protected]) Anti-alpha Tubulin antibody [DM1A] – Microtubule Marker (Alexa Fluor® 488) (ab195887)